SolarEdge posts FY 2025 financial expense net of ISO USD 72.0 million, up 394.2%

Reuters
02/25
<a href="https://laohu8.com/S/SEDG">SolarEdge</a> posts FY 2025 financial expense net of ISO USD 72.0 million, up 394.2%

SolarEdge reported FY 2025 revenue of USD 1.18 billion, up 31.4%, with gross profit of 16.6% and a net loss of USD 405.4 million. Operating loss was USD 301.7 million, while net cash provided by operating activities was USD 104.3 million; cash and cash equivalents totaled USD 455.1 million as of Dec. 31, 2025. For FY 2025, SolarEdge recognized 349.6 thousand inverters as revenue, 10.57 million power optimizers as revenue, and 897.4 MWh of batteries as revenue. The company said it launched its next-generation residential portfolio, SolarEdge Nexis, with initial units delivered toward the end of 2025, expanded its commercial storage offering with the CSS-OD 102.4 kWh solution, and transitioned its inverter products to a software-defined Single SKU concept. SolarEdge also highlighted its U.S. manufacturing footprint—producing most products domestically—and said it discontinued manufacturing in China, Mexico, and Hungary, while maintaining limited production in Israel and third-party manufacturing in Vietnam.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SolarEdge Technologies Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001178913-26-000632), on February 25, 2026, and is solely responsible for the information contained therein.

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10